BACKGROUND: People living with HIV (PLWH) experience high rates of mood disorders (major depression and bipolar affective disorder) which in the general population have been associated with noncommunicable disease (NCD) risk. We examined whether prevalent mood disorders are associated with incident NCDs and multimorbidity (accumulation of ≥2 NCDs) in PLWH. SETTING: Adult HIV clinic cohort in Nashville, Tennessee, between 1998 and 2015. METHODS: PLWH with ≥1 year of follow-up in the clinic were assessed for cardiovascular disease, metabolic syndrome (any 3 of hypertension, hyperlipidemia, diabetes, or obesity), chronic kidney and liver disease, non-AIDS-defining cancers, and dementia. Only mood disorders documented during the first year of care were included. Cumulative incidence and adjusted subhazard ratios (aSHRs) were calculated for risk of NCDs and multimorbidity with death as a competing risk. Multivariable Cox models estimated mortality risk after multimorbidity. RESULTS: Of 4140 adults, 24% had a mood disorder diagnosed in the first year of care, 51% had ≥1 NCD at baseline, and there were 2588 incident NCDs during the study period. Mood disorders were associated with increased risk of first NCD (aSHR = 1.29, 95% confidence interval: 1.06 to 1.57), incident multimorbidity (aSHR ranging from 1.04 to 1.42), and metabolic syndrome (aSHR = 1.29, 95% confidence interval: 1.02 to 1.64). Mood disorders were not conclusively associated with mortality risk after multimorbidity. CONCLUSIONS: PLWH with mood disorders were at increased risk of incident NCDs and multimorbidity, particularly metabolic syndrome. Focused prevention and treatment of NCDs may reduce the burden of multimorbidity in this high-risk group.
BACKGROUND: People living with HIV (PLWH) experience high rates of mood disorders (major depression and bipolar affective disorder) which in the general population have been associated with noncommunicable disease (NCD) risk. We examined whether prevalent mood disorders are associated with incident NCDs and multimorbidity (accumulation of ≥2 NCDs) in PLWH. SETTING: Adult HIV clinic cohort in Nashville, Tennessee, between 1998 and 2015. METHODS: PLWH with ≥1 year of follow-up in the clinic were assessed for cardiovascular disease, metabolic syndrome (any 3 of hypertension, hyperlipidemia, diabetes, or obesity), chronic kidney and liver disease, non-AIDS-defining cancers, and dementia. Only mood disorders documented during the first year of care were included. Cumulative incidence and adjusted subhazard ratios (aSHRs) were calculated for risk of NCDs and multimorbidity with death as a competing risk. Multivariable Cox models estimated mortality risk after multimorbidity. RESULTS: Of 4140 adults, 24% had a mood disorder diagnosed in the first year of care, 51% had ≥1 NCD at baseline, and there were 2588 incident NCDs during the study period. Mood disorders were associated with increased risk of first NCD (aSHR = 1.29, 95% confidence interval: 1.06 to 1.57), incident multimorbidity (aSHR ranging from 1.04 to 1.42), and metabolic syndrome (aSHR = 1.29, 95% confidence interval: 1.02 to 1.64). Mood disorders were not conclusively associated with mortality risk after multimorbidity. CONCLUSIONS: PLWH with mood disorders were at increased risk of incident NCDs and multimorbidity, particularly metabolic syndrome. Focused prevention and treatment of NCDs may reduce the burden of multimorbidity in this high-risk group.
Authors: K So-Armah; S K Gupta; S Kundu; J C Stewart; J L Goulet; A A Butt; J J Sico; V C Marconi; S Crystal; M C Rodriguez-Barradas; M Budoff; C L Gibert; C-Ch Chang; R Bedimo; M S Freiberg Journal: HIV Med Date: 2019-03-29 Impact factor: 3.180
Authors: Anna L Hotton; Kathleen M Weber; Ronald C Hershow; Kathryn Anastos; Peter Bacchetti; Elizabeth T Golub; Deborah Gustafson; Alexandra M Levine; Mary Young; Mardge H Cohen Journal: J Acquir Immune Defic Syndr Date: 2017-06-01 Impact factor: 3.731
Authors: Teppei Tanaka; Taro Matsuda; Lindsay N Hayes; Shuojia Yang; Katrina Rodriguez; Emily G Severance; Robert H Yolken; Akira Sawa; William W Eaton Journal: Neurosci Res Date: 2016-11-14 Impact factor: 3.304
Authors: Line D Rasmussen; Margaret T May; Gitte Kronborg; Carsten S Larsen; Court Pedersen; Jan Gerstoft; Niels Obel Journal: Lancet HIV Date: 2015-05-27 Impact factor: 12.767
Authors: Diana Nurutdinova; Timothy Chrusciel; Angelique Zeringue; Jeffrey F Scherrer; Ziyad Al-Aly; Jay R McDonald; Edgar T Overton Journal: AIDS Date: 2012-01-14 Impact factor: 4.177
Authors: Mario Catena-Dell'Osso; Francesco Rotella; Adriana Dell'Osso; Andrea Fagiolini; Donatella Marazziti Journal: Curr Drug Targets Date: 2013-05-01 Impact factor: 3.465
Authors: Victoria K Ngo; Adolfo Rubinstein; Vijay Ganju; Pamela Kanellis; Nasser Loza; Cristina Rabadan-Diehl; Abdallah S Daar Journal: PLoS Med Date: 2013-05-14 Impact factor: 11.069
Authors: Xiaoying Yu; Jacques Baillargeon; Abbey B Berenson; Jordan R Westra; Thomas P Giordano; Yong-Fang Kuo Journal: AIDS Date: 2022-05-25 Impact factor: 4.632
Authors: Julian J Weiss; Rachela Calvi; Mika Naganawa; Takuya Toyonaga; Shelli F Farhadian; Michelle Chintanaphol; Jennifer Chiarella; Ming-Qiang Zheng; Jim Ropchan; Yiyun Huang; Robert H Pietrzak; Richard E Carson; Serena Spudich Journal: Clin Infect Dis Date: 2021-10-20 Impact factor: 9.079